Transarterial Chemoembolization for Hepatocellular Carcinoma: An Evaluation of Long-Term Outcomes in Beijing, China
Sriwijaya Journal of Radiology and Imaging Research · 2024
DOI: 10.59345/sjrir.v2i2.162 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sriwijaya Journal of Radiology and Imaging Research, 2024. Verfasst von Xi Liang-Wu.
Abstract (Originalsprache)
Introduction
Transarterial chemoembolization (TACE) is a widely used treatment for unresectable hepatocellular carcinoma (HCC). This study aimed to evaluate the long-term outcomes of TACE in a cohort of patients with HCC in Beijing, China.
Methods
This retrospective cohort study included patients who underwent TACE for HCC at a tertiary care hospital in Beijing, China, between 2010 and 2018. Data on patient demographics, tumor characteristics, treatment details, and outcomes were collected from medical records. Overall survival (OS) and progression-free survival (PFS) were the primary endpoints. Survival analysis was performed using the Kaplan-Meier method and Cox proportional hazards regression.
Results
A total of 352 patients were included in the study. The median follow-up duration was 48 months (range: 6-120 months). The median OS was 36 months, and the 5-year OS rate was 28%. The median PFS was 12 months, and the 3-year PFS rate was 15%. Tumor size, Barcelona Clinic Liver Cancer (BCLC) stage, and alpha-fetoprotein (AFP) level were independent predictors of OS and PFS.
Conclusion
TACE can provide long-term survival benefits for patients with HCC in Beijing, China. Tumor size, BCLC stage, and AFP level are important prognostic factors for TACE outcomes.
Zitieren
APA
Liang-Wu, X. (2024). Transarterial Chemoembolization for Hepatocellular Carcinoma: An Evaluation of Long-Term Outcomes in Beijing, China. Sriwijaya Journal of Radiology and Imaging Research. https://doi.org/10.59345/sjrir.v2i2.162
Vancouver
Liang-Wu X. Transarterial Chemoembolization for Hepatocellular Carcinoma: An Evaluation of Long-Term Outcomes in Beijing, China. Sriwijaya Journal of Radiology and Imaging Research. 2024. doi:10.59345/sjrir.v2i2.162
BibTeX
@article{LiangWu2024,
author = {Liang-Wu, Xi},
title = {Transarterial Chemoembolization for Hepatocellular Carcinoma: An Evaluation of Long-Term Outcomes in Beijing, China},
journal = {Sriwijaya Journal of Radiology and Imaging Research},
year = {2024},
doi = {10.59345/sjrir.v2i2.162}
}
EUVIMED